Literature DB >> 19648276

Original antigenic sin responses to influenza viruses.

Jin Hyang Kim1, Ioanna Skountzou, Richard Compans, Joshy Jacob.   

Abstract

Most immune responses follow Burnet's rule in that Ag recruits specific lymphocytes from a large repertoire and induces them to proliferate and differentiate into effector cells. However, the phenomenon of "original antigenic sin" stands out as a paradox to Burnet's rule of B cell engagement. Humans, upon infection with a novel influenza strain, produce Abs against older viral strains at the expense of responses to novel, protective antigenic determinants. This exacerbates the severity of the current infection. This blind spot of the immune system and the redirection of responses to the "original Ag" rather than to novel epitopes were described fifty years ago. Recent reports have questioned the existence of this phenomenon. Hence, we revisited this issue to determine the extent to which original antigenic sin is induced by variant influenza viruses. Using two related strains of influenza A virus, we show that original antigenic sin leads to a significant decrease in development of protective immunity and recall responses to the second virus. In addition, we show that sequential infection of mice with two live influenza virus strains leads to almost exclusive Ab responses to the first viral strain, suggesting that original antigenic sin could be a potential strategy by which variant influenza viruses subvert the immune system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648276      PMCID: PMC4460008          DOI: 10.4049/jimmunol.0900398

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Influenza: the new acquayantance.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1953-08       Impact factor: 25.391

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Nicole M Smith; Joseph S Bresee; David K Shay; Timothy M Uyeki; Nancy J Cox; Raymond A Strikas
Journal:  MMWR Recomm Rep       Date:  2006-07-28

4.  Original antigenic sin at the cellular level. II. Specificity of the antibodies produced by individual cells.

Authors:  S Deutsch; M A Vinit; A E Bussard
Journal:  Eur J Immunol       Date:  1973-04       Impact factor: 5.532

5.  Original antigenic sin at the cellular level. I. Antibodies produced by individual cells against cross-reacting haptens.

Authors:  S Deutsch; A E Bussard
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

6.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-04-30

Review 7.  The role of cytokines in the immune response to influenza A virus infection.

Authors:  T Sládková; F Kostolanský
Journal:  Acta Virol       Date:  2006       Impact factor: 1.162

Review 8.  Influenza: old and new threats.

Authors:  Peter Palese
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

9.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

10.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

View more
  132 in total

Review 1.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

2.  A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants.

Authors:  Wilfred Ndifon
Journal:  J R Soc Interface       Date:  2015-11-06       Impact factor: 4.118

Review 3.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

Review 4.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

Review 5.  Protective B cell responses to flu--no fluke!

Authors:  Elizabeth E Waffarn; Nicole Baumgarth
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

6.  Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C.

Authors:  Cibele M Gaido; Shane Stone; Abha Chopra; Wayne R Thomas; Peter N Le Souëf; Belinda J Hales
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 7.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

8.  Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course.

Authors:  John Patrick Haran; David C Hoaglin; Huaiqing Chen; Edward W Boyer; Shan Lu
Journal:  J Clin Virol       Date:  2014-05-28       Impact factor: 3.168

Review 9.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

10.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.